These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34062774)

  • 1. 40 Years of RAS-A Historic Overview.
    Fernández-Medarde A; De Las Rivas J; Santos E
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34062774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A perspective on the early days of RAS research.
    Weiss RA
    Cancer Metastasis Rev; 2020 Dec; 39(4):1023-1028. PubMed ID: 32728828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic RAS: From Its Activation to Its Direct Targeting.
    Zaravinos A
    Crit Rev Oncog; 2017; 22(3-4):283-301. PubMed ID: 29604905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting.
    Shu L; Wang D; Saba NF; Chen ZG
    Mol Cancer Ther; 2020 Apr; 19(4):999-1007. PubMed ID: 32241873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RAS-Effector Interaction as a Drug Target.
    Keeton AB; Salter EA; Piazza GA
    Cancer Res; 2017 Jan; 77(2):221-226. PubMed ID: 28062402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAS-mediated oncogenic signaling pathways in human malignancies.
    Khan AQ; Kuttikrishnan S; Siveen KS; Prabhu KS; Shanmugakonar M; Al-Naemi HA; Haris M; Dermime S; Uddin S
    Semin Cancer Biol; 2019 Feb; 54():1-13. PubMed ID: 29524560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ras superfamily of small GTPases: the unlocked secrets.
    Goitre L; Trapani E; Trabalzini L; Retta SF
    Methods Mol Biol; 2014; 1120():1-18. PubMed ID: 24470015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers.
    Aguilar BJ; Zhou H; Lu Q
    Curr Med Chem; 2017; 24(32):3485-3507. PubMed ID: 28571533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids.
    Wiechmann S; Maisonneuve P; Grebbin BM; Hoffmeister M; Kaulich M; Clevers H; Rajalingam K; Kurinov I; Farin HF; Sicheri F; Ernst A
    J Biol Chem; 2020 Apr; 295(14):4526-4540. PubMed ID: 32086379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brief history of RAS and the RAS Initiative.
    McCormick F
    Adv Cancer Res; 2022; 153():1-27. PubMed ID: 35101227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Approaches to RAS Mutation.
    Scott AJ; Lieu CH; Messersmith WA
    Cancer J; 2016; 22(3):165-74. PubMed ID: 27341593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers.
    Mattox TE; Chen X; Maxuitenko YY; Keeton AB; Piazza GA
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Ras with Macromolecules.
    Pei D; Chen K; Liao H
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28778966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in cancer drug discovery targeting RAS.
    Wilson CY; Tolias P
    Drug Discov Today; 2016 Dec; 21(12):1915-1919. PubMed ID: 27506872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past, Present, and Future of Targeting Ras for Cancer Therapies.
    Tan Z; Zhang S
    Mini Rev Med Chem; 2016; 16(5):345-57. PubMed ID: 26423695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemically-controlled system for activating RAS GTPases.
    Dieter EM; Maly DJ
    Methods Enzymol; 2020; 633():103-117. PubMed ID: 32046841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding and drugging RAS: 40 years to break the tip of the iceberg.
    Brady DC; Hmeljak J; Dar AC
    Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35244677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small change, big effect: Taking RAS by the tail through suppression of post-prenylation carboxylmethylation.
    Lau HY; Wang M
    Small GTPases; 2020 Jul; 11(4):271-279. PubMed ID: 29261009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kirsten Ras* oncogene: significance of its discovery in human cancer research.
    Tsuchida N; Murugan AK; Grieco M
    Oncotarget; 2016 Jul; 7(29):46717-46733. PubMed ID: 27102293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical biology tools for regulating RAS signaling complexity in space and time.
    van Hattum H; Waldmann H
    Chem Biol; 2014 Sep; 21(9):1185-95. PubMed ID: 25237862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.